Antiarrhythmic agent

From WikiMD.org
Jump to navigation Jump to search

Antiarrhythmic agent

Antiarrhythmic agents (pronounced: an-tee-ar-rith-mic agents) are a group of pharmaceuticals that are used to suppress abnormal rhythms of the heart (cardiac arrhythmias), such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation.

Etymology

The term "antiarrhythmic agent" is derived from the Greek words "anti" meaning against, "arrhythmia" meaning without rhythm, and "agent" meaning something that produces an effect.

Classification

Antiarrhythmic agents are classified into four main classes (I, II, III, IV) according to the Vaughan Williams classification, which is based on the primary mechanism of action.

Related Terms

  • Arrhythmia: A condition in which the heart beats with an irregular or abnormal rhythm.
  • Atrial fibrillation: A quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications.
  • Ventricular tachycardia: A fast, abnormal heart rate that begins in the lower chambers of the heart (ventricles).
  • Ventricular fibrillation: A life-threatening cardiac condition characterized by rapid, irregular heartbeats.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski